Role of Screening for Heavy Menstrual Bleeding in Women and Girls with Sickle Cell Disease
S
Seethal Jacob, MD
Primary Investigator
Overview
The primary objective of this study is to implement a modified menstrual bleeding
assessment for all females with SCD to determine the scope of dysfunctional menstrual
bleeding, assess its role in the health of these individuals while encouraging providers to
take action when these scores are high to avoid delays in work up and subspecialty care.
Description
In this study, we aim to implement a validated menstrual bleeding questionnaire
(MBQ) and a patient survey to all menstruating females with SCD followed at sickle cell
centers across the U.S. during their scheduled sickle cell visits. In addition, we also aim to
implement a provider survey for each patient enrolled at UCSF Oakland (with the
provider survey being optional at all other sites) to assess health care utilization, patient
laboratory data and steps taken by the provider after reviewing the patient questionnaire
results.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
sickle cell, menstruation
-
Age: Between 12 Years - 100 Years
-
Gender: Female
Inclusion Criteria:
- Women and girls with sickle cell disease diagnosis (all genotypes) Has experienced menstrual bleeding within the past 12 months Able to read, write, and understand English OR site has materials in another language and/or key study personnel fluent in another language and obtains local IRB approval for carrying out study in another language Menarche at least 12 months prior to enrollment May or may not be on contraceptive/hormonal therapy
Exclusion Criteria:
- Pregnancy Menarche within the past 12 months Post menopausal
Updated on
27 Apr 2024.
Study ID: 16382; PCHSR-UCSF-SCD
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
